Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-27

Clinical Trial Update: PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized trial investigating PTH(1-34) for healing osteoporotic fractures completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PTH(1-34) (teriparatide)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Osteoporotic Fractures | Phase 2 | Status: COMPLETED | Results posted: 2022-07-27